The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in Korea

PURPOSE: The 21-gene (Oncotype DX) recurrence score (RS) assay is useful in predicting the benefits of adjuvant chemotherapy for early breast cancer patients and is widely used in Western countries. However, to date, it has not gained much popularity in East Asia. We analyzed the results from five i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Moo Hyun, Han, Wonshik, Lee, Jeong Eon, Kim, Ku Sang, Park, Heeseung, Kim, Jongjin, Bae, Soo Youn, Shin, Hyun Joo, Lee, Jong Won, Lee, Eun Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398124/
https://www.ncbi.nlm.nih.gov/pubmed/25381828
http://dx.doi.org/10.4143/crt.2013.223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398124/
https://www.ncbi.nlm.nih.gov/pubmed/25381828
http://dx.doi.org/10.4143/crt.2013.223

Ejemplares similares